The deal covers Canon BioMedical's Novallele line of genotyping and copy number assays in Austria, Germany, and Switzerland.

Sanbio, a Netherlands-based distributor that serves the Belgium, the Netherlands, and Luxembourg, will distribute Canon's Novallele assays and controls.

The method uses chitosan-coated magnetic beads and bead-based lysis to reduce the number of sample prep steps. 

The companies have been working together since early 2015 on a diagnostic for the early detection of Lyme disease.

The firm has launched genotyping assays that rely on PCR followed by high-resolution melt analysis, as well as master mix companion chemistry.

The investment will fund the research and development of new diagnostic testing products, including rapid genetic testing.

Among Canon BioMedical's life science projects is a genetic testing platform based on ultra-fast serial PCR and high-resolution melt analysis.

The partners will work together to build a rapid diagnostic test panel for Lyme Disease using T2's magnetic resonance detection technology. 

Beckman Coulter has been awarded

The Regents of the University of California have been awarded


Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.